Kimelman & Baird’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.6M | Sell |
10,250
-200
| -2% | -$46.6K | 0.19% | 54 |
|
|
2026
Q1 | $2.55M | Buy |
10,450
+54
| +0.5% | +$12.6K | 0.21% | 52 |
|
|
2025
Q4 | $2.15M | Hold |
10,396
| – | – | 0.17% | 54 |
|
|
2025
Q3 | $1.93M | Hold |
10,396
| – | – | 0.15% | 53 |
|
|
2025
Q2 | $1.59M | Hold |
10,396
| – | – | 0.13% | 56 |
|
|
2025
Q1 | $1.72M | Hold |
10,396
| – | – | 0.15% | 50 |
|
|
2024
Q4 | $1.5M | Hold |
10,396
| – | – | 0.12% | 55 |
|
|
2024
Q3 | $1.68M | Hold |
10,396
| – | – | 0.13% | 57 |
|
|
2024
Q2 | $1.52M | Buy |
+10,396
| New | +$1.55M | 0.13% | 55 |
|
|
2021
Q2 | $1.61M | Buy |
+9,800
| New | +$1.62M | 0.14% | 59 |
|
|
2019
Q3 | $1.28M | Sell |
9,900
-3,225
| -25% | -$425K | 0.18% | 56 |
|
|
2019
Q2 | $1.83M | Hold |
13,125
| – | – | 0.25% | 52 |
|
|
2019
Q1 | $1.83M | Sell |
13,125
-2,100
| -14% | -$281K | 0.26% | 53 |
|
|
2018
Q4 | $1.97M | Sell |
15,225
-1,262
| -8% | -$176K | 0.31% | 52 |
|
|
2018
Q3 | $2.28M | Hold |
16,487
| – | – | 0.29% | 53 |
|
|
2018
Q2 | $2M | Buy |
+16,487
| New | +$2.06M | 0.26% | 55 |
|
|
2017
Q4 | $2.36M | Hold |
16,867
| – | – | 0.34% | 51 |
|
|
2017
Q3 | $2.19M | Hold |
16,867
| – | – | 0.33% | 53 |
|
|
2017
Q2 | $2.23M | Hold |
16,867
| – | – | 0.34% | 54 |
|
|
2017
Q1 | $2.1M | Hold |
16,867
| – | – | 0.32% | 52 |
|
|
2016
Q4 | $1.94M | Hold |
16,867
| – | – | 0.33% | 48 |
|
|
2016
Q3 | $1.99M | Sell |
16,867
-500
| -3% | -$60.7K | 0.35% | 49 |
|
|
2016
Q2 | $2.11M | Hold |
17,367
| – | – | 0.39% | 50 |
|
|
2016
Q1 | $1.88M | Buy |
17,367
+100
| +0.6% | +$10.4K | 0.35% | 50 |
|
|
2015
Q4 | $1.77M | Buy |
+17,267
| New | +$1.74M | 0.33% | 55 |
|
|
2015
Q2 | $1.74M | Sell |
17,807
-1,595
| -8% | -$160K | 0.3% | 61 |
|
|
2015
Q1 | $1.95M | Sell |
19,402
-1,000
| -5% | -$102K | 0.36% | 56 |
|
|
2014
Q4 | $2.13M | Sell |
20,402
-380
| -2% | -$40K | 0.38% | 54 |
|
|
2014
Q3 | $2.21M | Hold |
20,782
| – | – | 0.42% | 53 |
|
|
2014
Q2 | $2.17M | Buy |
20,782
+30
| +0.1% | +$3.03K | 0.38% | 55 |
|
|
2014
Q1 | $2.04M | Hold |
20,752
| – | – | 0.38% | 53 |
|
|
2013
Q4 | $1.9M | Hold |
20,752
| – | – | 0.36% | 56 |
|
|
2013
Q3 | $1.8M | Hold |
20,752
| – | – | 0.36% | 58 |
|
|
2013
Q2 | $1.78M | Buy |
+20,752
| New | +$1.76M | 0.38% | 57 |
|
Other funds holding JNJ
Kimelman & Baird's JNJ Position: Q2 2026 in Review
Kimelman & Baird reduced its Johnson & Johnson (JNJ) stake by 1.9% in Q2 2026, selling an estimated $46.6K and leaving 10,250 shares worth $2.6M. The position accounts for 0.19% of the portfolio, ranked #54.
Kimelman & Baird first reported a position in JNJ in Q2 2013 and has held it in 34 quarters since. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Kimelman & Baird held 10,250 shares of Johnson & Johnson worth $2.6M as of Q2 2026.
- Kimelman & Baird sold 200 Johnson & Johnson shares in Q2 2026, an estimated $46.6K.
- Johnson & Johnson made up 0.19% of Kimelman & Baird's portfolio in Q2 2026, its #54 holding.
- Kimelman & Baird first reported a position in Johnson & Johnson in Q2 2013 and has held it in 34 quarters since.
- 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Kimelman & Baird's 13F filing for Q2 2026, filed 5 Aug 2026.